Literature DB >> 24646489

Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking.

Hong-Kee Tan1, Cheng-Xu Delon Toh, Dongrui Ma, Binxia Yang, Tong Ming Liu, Jun Lu, Chee-Wai Wong, Tze-Kai Tan, Hu Li, Christopher Syn, Eng-Lee Tan, Bing Lim, Yoon-Pin Lim, Stuart A Cook, Yuin-Han Loh.   

Abstract

Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients can be a good model for studying human diseases and for future therapeutic regenerative medicine. Current initiatives to establish human iPSC (hiPSC) banking face challenges in recruiting large numbers of donors with diverse diseased, genetic, and phenotypic representations. In this study, we describe the efficient derivation of transgene-free hiPSCs from human finger-prick blood. Finger-prick sample collection can be performed on a "do-it-yourself" basis by donors and sent to the hiPSC facility for reprogramming. We show that single-drop volumes of finger-prick samples are sufficient for performing cellular reprogramming, DNA sequencing, and blood serotyping in parallel. Our novel strategy has the potential to facilitate the development of large-scale hiPSC banking worldwide.

Entities:  

Keywords:  Finger prick; Human induced pluripotent stem cell banking; Human peripheral blood; Induced pluripotent stem cells; Reprogramming

Mesh:

Year:  2014        PMID: 24646489      PMCID: PMC4006490          DOI: 10.5966/sctm.2013-0195

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  41 in total

1.  Determination of ABO genotypes by real-time PCR using allele-specific primers.

Authors:  Tomonori Muro; Junko Fujihara; Shinji Imamura; Hiroaki Nakamura; Kaori Kimura-Kataoka; Tomoko Toga; Reiko Iida; Toshihiro Yasuda; Haruo Takeshita
Journal:  Leg Med (Tokyo)       Date:  2011-12-16       Impact factor: 1.376

2.  Early TCR expression and aberrant T cell development in mice with endogenous prerearranged T cell receptor genes.

Authors:  Thomas Serwold; Konrad Hochedlinger; Matthew A Inlay; Rudolf Jaenisch; Irving L Weissman
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

3.  Reprogramming of human peripheral blood cells to induced pluripotent stem cells.

Authors:  Judith Staerk; Meelad M Dawlaty; Qing Gao; Dorothea Maetzel; Jacob Hanna; Cesar A Sommer; Gustavo Mostoslavsky; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2010-07-02       Impact factor: 24.633

4.  Rapid Rh D genotyping by polymerase chain reaction-based amplification of DNA.

Authors:  S Simsek; B H Faas; P M Bleeker; M A Overbeeke; H T Cuijpers; C E van der Schoot; A E von dem Borne
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113

5.  The majority of the in vitro erythroid expansion potential resides in CD34(-) cells, outweighing the contribution of CD34(+) cells and significantly increasing the erythroblast yield from peripheral blood samples.

Authors:  Emile van den Akker; Timothy J Satchwell; Stephanie Pellegrin; Geoff Daniels; Ashley M Toye
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

6.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

Review 7.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Authors:  J J M van Dongen; A W Langerak; M Brüggemann; P A S Evans; M Hummel; F L Lavender; E Delabesse; F Davi; E Schuuring; R García-Sanz; J H J M van Krieken; J Droese; D González; C Bastard; H E White; M Spaargaren; M González; A Parreira; J L Smith; G J Morgan; M Kneba; E A Macintyre
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

8.  Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2.

Authors:  Alessandra Giorgetti; Nuria Montserrat; Trond Aasen; Federico Gonzalez; Ignacio Rodríguez-Pizà; Rita Vassena; Angel Raya; Stéphanie Boué; Maria Jose Barrero; Begoña Aran Corbella; Marta Torrabadella; Anna Veiga; Juan Carlos Izpisua Belmonte
Journal:  Cell Stem Cell       Date:  2009-10-02       Impact factor: 24.633

9.  Generation of induced pluripotent stem cells from human cord blood.

Authors:  Alexandra Haase; Ruth Olmer; Kristin Schwanke; Stephanie Wunderlich; Sylvia Merkert; Christian Hess; Robert Zweigerdt; Ina Gruh; Johann Meyer; Stefan Wagner; Lars S Maier; Dong Wook Han; Silke Glage; Konstantin Miller; Philipp Fischer; Hans R Schöler; Ulrich Martin
Journal:  Cell Stem Cell       Date:  2009-10-02       Impact factor: 24.633

10.  Disease-specific induced pluripotent stem cells.

Authors:  In-Hyun Park; Natasha Arora; Hongguang Huo; Nimet Maherali; Tim Ahfeldt; Akiko Shimamura; M William Lensch; Chad Cowan; Konrad Hochedlinger; George Q Daley
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582

View more
  16 in total

1.  Human Induced Pluripotent Stem Cell Production and Expansion from Blood using a Non-Integrating Viral Reprogramming Vector.

Authors:  Arun Sharma; Michael Mücke; Christine E Seidman
Journal:  Curr Protoc Mol Biol       Date:  2018-04

2.  Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells.

Authors:  Ras Trokovic; Jere Weltner; Ken Nishimura; Manami Ohtaka; Mahito Nakanishi; Veikko Salomaa; Anu Jalanko; Timo Otonkoski; Aija Kyttälä
Journal:  Stem Cells Transl Med       Date:  2014-10-29       Impact factor: 6.940

Review 3.  Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.

Authors:  I K Rony; A Baten; J A Bloomfield; M E Islam; M M Billah; K D Islam
Journal:  Cell Prolif       Date:  2015-01-29       Impact factor: 6.831

Review 4.  An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.

Authors:  Manash P Borgohain; Krishna Kumar Haridhasapavalan; Chandrima Dey; Poulomi Adhikari; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

5.  A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.

Authors:  Bin-Kuan Chou; Haihui Gu; Yongxing Gao; Sarah N Dowey; Ying Wang; Jun Shi; Yanxin Li; Zhaohui Ye; Tao Cheng; Linzhao Cheng
Journal:  Stem Cells Transl Med       Date:  2015-03-05       Impact factor: 6.940

Review 6.  Progress and challenges in the development of a cell-based therapy for hemophilia A.

Authors:  M E Fomin; P P Togarrati; M O Muench
Journal:  J Thromb Haemost       Date:  2014-10-31       Impact factor: 5.824

Review 7.  Personalized therapeutic strategies for patients with retinitis pigmentosa.

Authors:  Andrew Zheng; Yao Li; Stephen H Tsang
Journal:  Expert Opin Biol Ther       Date:  2015-01-23       Impact factor: 4.388

8.  Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.

Authors:  Hongyan Zhou; Hector Martinez; Bruce Sun; Aiqun Li; Matthew Zimmer; Nicholas Katsanis; Erica E Davis; Joanne Kurtzberg; Scott Lipnick; Scott Noggle; Mahendra Rao; Stephen Chang
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

Review 9.  A Comparative View on Human Somatic Cell Sources for iPSC Generation.

Authors:  Stefanie Raab; Moritz Klingenstein; Stefan Liebau; Leonhard Linta
Journal:  Stem Cells Int       Date:  2014-11-06       Impact factor: 5.443

Review 10.  An Overview on Promising Somatic Cell Sources Utilized for the Efficient Generation of Induced Pluripotent Stem Cells.

Authors:  Arnab Ray; Jahnavy Madhukar Joshi; Pradeep Kumar Sundaravadivelu; Khyati Raina; Nibedita Lenka; Vishwas Kaveeshwar; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2021-06-07       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.